About this item:

81 Views | 37 Downloads

Author Notes:

J. Lucas McKay, lucas@dbmi.emory.edu

Conceptualization, H.K., S.F., and L.M.; methodology, H.K.; software, H.K.; validation, H.K., I.G., and L.M.; formal analysis, H.K. and L.M.; investigation, H.K. and L.M.; resources, S.F., L.M., G.D., and C.E.; data curation, D.B. and L.M.; writing—original draft preparation, H.K.; writing—review and editing, L.M., G.D., I.G., C.E., S.F.; visualization, H.K.; supervision, G.D., L.M., and S.F.; project administration, L.M. and S.F.; funding acquisition, S.F. and L.M. All authors have read and agreed to the published version of the manuscript.

The computational needs for this research are supported in part by Oracle Cloud credits and related resources provided by the Oracle for Research program.

J.L.M. performs paid consulting work for Biocircuit technologies. None of these interests are directly related to the outcomes of this study. S.A.F. has the following competing interests: Honoraria: Lundbeck, Teva, Sunovion, Biogen, Acadia, Neuroderm, Acorda, CereSpire. Grants: Ipsen, Medtronics, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, Lilly, CHDI Foundation, Michael J. Fox Foundation, NIH, Royalties: Demos, Blackwell Futura for textbooks, Uptodate, Other Bracket Global LLC, CNS Ratings LLC. None of these interests are directly related to the outcomes of this study. The other authors declare no other interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Subject:

Research Funding:

This research was funded by The McCamish Center for Parkinson’s Disease Innovation, the by Curtis Family Fund, Sartain Lanier Family Foundation (S.A.F.), and NIH K25HD086276 (J.L.M.).

Keywords:

  • parkinsonian patients

An explainable spatial-temporal graphical convolutional network to score freezing of gait in parkinsonian patients.

Tools:

Journal Title:

medRxiv

Publisher:

Type of Work:

Article | Preprint: Prior to Peer Review

Abstract:

Freezing of gait (FOG) is a poorly understood heterogeneous gait disorder seen in patients with parkinsonism which contributes to significant morbidity and social isolation. FOG is currently measured with scales that are typically performed by movement disorders specialists (ie. MDS-UPDRS), or through patient completed questionnaires (N-FOG-Q) both of which are inadequate in addressing the heterogeneous nature of the disorder and are unsuitable for use in clinical trials The purpose of this study was to devise a method to measure FOG objectively, hence improving our ability to identify it and accurately evaluate new therapies. We trained interpretable deep learning models with multi-task learning to simultaneously score FOG (cross-validated F1 score 97.6%), identify medication state (OFF vs. ON levodopa; cross-validated F1 score 96.8%), and measure total PD severity (MDS-UPDRS-III score prediction error ≤ 2.7 points) using kinematic data of a well-characterized sample of N=57 patients during levodopa challenge tests. The proposed model was able to identify kinematic features associated with each FOG severity level that were highly consistent with the features that movement disorders specialists are trained to identify as characteristic of freezing. In this work, we demonstrate that deep learning models' capability to capture complex movement patterns in kinematic data can automatically and objectively score FOG with high accuracy. These models have the potential to discover novel kinematic biomarkers for FOG that can be used for hypothesis generation and potentially as clinical trial outcome measures.

Copyright information:

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote